Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (7318)	9/25/1998 12:15:00 PM
From: Robert K.	Read Replies (1) \| Respond to of 17367

Important (positive or negative)>>>Local radio news in my area is reporting a story to this effect. 1>new antibiotic nearing the end phase of human testing that kills a wide range of bacteria resistant to antibiotics. Works in a novel way and resistance is not expected to occur. >>Thats all I can remember as best I can remember. name of drug or company not mentioned

To: aknahow who wrote (7318)	9/25/1998 2:03:00 PM
From: Robert K.	Read Replies (1) \| Respond to of 17367

Story again> about a 30 to 40 second spot>>>>>>>>>>>>>>>>>>>> Something like>>>> There may be a new class of drugs to fight resistant infections, or superbugs. The drug(s) act in a unique way to kill bacteria and may never be able to develop resistance. At the american society of microbiologist meeting (thats Icaac) researchers are now completing final tests on humans before they seek fda approval. end Thats pretty much what is coming over the air. Good luck